Good morning,
My pick of the day is Viral Genetics (VRAL). This penny stock has good news yesterday and might be looking to do great today.
"Enrollment and treatment of patients is expected to commence
upon completion of internal hospital Institutional Review Boards (IRBs), which
are already underway. The UT Health Science Center portion of the study will
commence when all approvals are finalized.
This clinical trial -- a milestone in the Company's
transition from preclinical to clinical-stage -- will be the first for the
intellectual property developed by Dr. M. Karen Newell Rogers, Viral Genetics'
Chief Scientist and licensed exclusively by the Company. It will examine the
safety and efficacy of one of Viral Genetics licensed MDT compounds in
combination with an existing cancer drug, sorafenib (marketed as Nexavar(TM))
in the treatment of patients resistant or otherwise unsuitable for standard treatments
for stage III or IV ovarian cancer and related carcinomas." (Wire news)
Medical always tend to bring good results in the stocks market. Let's hope this one will be one of the many that have done great thus far.
You are advised to conduct your own research first before trading with any stock.
Good luck trading!
No comments:
Post a Comment